These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17407810)

  • 1. Porous hydroxyapatite tablets as carriers for low-dosed drugs.
    Cosijns A; Vervaet C; Luyten J; Mullens S; Siepmann F; Van Hoorebeke L; Masschaele B; Cnudde V; Remon JP
    Eur J Pharm Biopharm; 2007 Sep; 67(2):498-506. PubMed ID: 17407810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug release behaviour from methyl methacrylate-starch matrix tablets: effect of polymer moisture content.
    Bravo-Osuna I; Ferrero C; Jiménez-Castellanos MR
    Eur J Pharm Biopharm; 2008 May; 69(1):285-93. PubMed ID: 17997292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-amylose sodium carboxymethyl starch matrices for oral, sustained drug-release: formulation aspects and in vitro drug-release evaluation.
    Brouillet F; Bataille B; Cartilier L
    Int J Pharm; 2008 May; 356(1-2):52-60. PubMed ID: 18280069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility, stability and release performance of a time-dependent insulin delivery system intended for oral colon release.
    Maroni A; Del Curto MD; Serratoni M; Zema L; Foppoli A; Gazzaniga A; Sangalli ME
    Eur J Pharm Biopharm; 2009 May; 72(1):246-51. PubMed ID: 19121388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid boundary movements in cylindrical and convex hydrophobic matrix tablets: Effects on tablet cracking and drug release.
    Pajander J; van Veen B; Korhonen O; Lappalainen R; Ketolainen J
    Eur J Pharm Biopharm; 2006 Oct; 64(2):167-72. PubMed ID: 16846722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Citric acid monohydrate as a release-modifying agent in melt extruded matrix tablets.
    Schilling SU; Bruce CD; Shah NH; Malick AW; McGinity JW
    Int J Pharm; 2008 Sep; 361(1-2):158-68. PubMed ID: 18582547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of multivariate methods to compression behavior evaluation of directly compressible materials.
    Haware RV; Tho I; Bauer-Brandl A
    Eur J Pharm Biopharm; 2009 May; 72(1):148-55. PubMed ID: 19084596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and evaluation of floating multi-layer coated tablets based on gas formation.
    Sungthongjeen S; Sriamornsak P; Puttipipatkhachorn S
    Eur J Pharm Biopharm; 2008 May; 69(1):255-63. PubMed ID: 17967527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and evaluation of colon specific drug delivery system containing flurbiprofen microsponges.
    Orlu M; Cevher E; Araman A
    Int J Pharm; 2006 Aug; 318(1-2):103-17. PubMed ID: 16687222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low density porous carrier drug adsorption and release study by response surface methodology using different solvents.
    Sher P; Ingavle G; Ponrathnam S; Pawar AP
    Int J Pharm; 2007 Feb; 331(1):72-83. PubMed ID: 17030470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and characterisation of interactive mixtures with a fine-particulate mucoadhesive carrier for nasal drug delivery.
    Fransén N; Björk E; Nyström C
    Eur J Pharm Biopharm; 2007 Sep; 67(2):370-6. PubMed ID: 17451925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of sol-gel mesoporous silica materials providing a slow release of doxorubicin.
    Prokopowicz M; Przyjazny A
    J Microencapsul; 2007 Nov; 24(7):682-701. PubMed ID: 17763062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graft copolymers of ethyl methacrylate on waxy maize starch derivatives as novel excipients for matrix tablets: physicochemical and technological characterisation.
    Marinich JA; Ferrero C; Jiménez-Castellanos MR
    Eur J Pharm Biopharm; 2009 May; 72(1):138-47. PubMed ID: 19146956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theophylline loaded gastroretentive floating tablets based on hydrophilic polymers: preparation and in vitro evaluation.
    Khan F; Ibn Razzak SM; Khan ZR; Azad MA; Chowdhury JA; Reza S
    Pak J Pharm Sci; 2009 Apr; 22(2):155-61. PubMed ID: 19339225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of polymeric subcoats on the drug release properties of tablets powder-coated with pre-plasticized Eudragit L 100-55.
    Sauer D; Watts AB; Coots LB; Zheng WC; McGinity JW
    Int J Pharm; 2009 Feb; 367(1-2):20-8. PubMed ID: 18848872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fabrication of HA/TCP scaffolds with a graded and porous structure using a camphene-based freeze-casting method.
    Macchetta A; Turner IG; Bowen CR
    Acta Biomater; 2009 May; 5(4):1319-27. PubMed ID: 19112055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ibuprofen-loaded calcium phosphate granules: combination of innovative characterization methods to relate mechanical strength to drug location.
    Chevalier E; Viana M; Cazalbou S; Makein L; Dubois J; Chulia D
    Acta Biomater; 2010 Jan; 6(1):266-74. PubMed ID: 19654055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frosta: a new technology for making fast-melting tablets.
    Jeong SH; Fu Y; Park K
    Expert Opin Drug Deliv; 2005 Nov; 2(6):1107-16. PubMed ID: 16296813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deeper insight into the drug release mechanisms in Eudragit RL-based delivery systems.
    Glaessl B; Siepmann F; Tucker I; Rades T; Siepmann J
    Int J Pharm; 2010 Apr; 389(1-2):139-46. PubMed ID: 20105459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.